CAW
TEVA icon

Cornerstone Advisors (Washington)’s Teva Pharmaceuticals TEVA Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$22K Sell
2,435
-222
-8% -$2.35K ﹤0.01% 363
2020
Q2 		$33K Buy
2,657
+179
+7% +$2.02K ﹤0.01% 332
2020
Q1 		$22K Sell
2,478
-84
-3% -$861 ﹤0.01% 334
2019
Q4 		$25K Buy
2,562
+34
+1% +$304 ﹤0.01% 326
2019
Q3 		$17K Buy
2,528
+2,045
+423% +$15.7K ﹤0.01% 352
2019
Q2 		$4K Buy
483
+87
+22% +$1.05K ﹤0.01% 990
2019
Q1 		$6K Buy
396
+171
+76% +$3.02K ﹤0.01% 808
2018
Q4 		$3K Sell
225
-167
-43% -$3.42K ﹤0.01% 847
2018
Q3 		$8K Buy
392
+103
+36% +$2.39K 0.01% 696
2018
Q2 		$7K Buy
289
+48
+20% +$979 ﹤0.01% 679
2018
Q1 		$4K Buy
241
+154
+177% +$3.01K ﹤0.01% 747
2017
Q4 		$2K Buy
+87
New +$1.31K ﹤0.01% 825
2017
Q2 		– Sell
-164
Closed -$5K – 924
2017
Q1 		$5K Hold
164
– – ﹤0.01% 699
2016
Q4 		$6K Sell
164
-79
-33% -$3.15K 0.01% 683
2016
Q3 		$11K Buy
243
+31
+15% +$1.62K 0.01% 581
2016
Q2 		$11K Sell
212
-15
-7% -$799 0.01% 412
2016
Q1 		$12K Hold
227
– – 0.01% 386
2015
Q4 		$15K Hold
227
– – 0.02% 373
2015
Q3 		$13K Hold
227
– – 0.01% 397
2015
Q2 		$13K Hold
227
– – 0.01% 303
2015
Q1 		$14K Hold
227
– – 0.01% 325
2014
Q4 		$13K Buy
227
+44
+24% +$2.45K 0.01% 294
2014
Q3 		$10K Hold
183
– – 0.01% 191
2014
Q2 		$10K Hold
183
– – 0.01% 210
2014
Q1 		$10K Sell
183
-136
-43% -$6.29K 0.01% 205
2013
Q4 		$13K Hold
319
– – 0.02% 129
2013
Q3 		$12K Hold
319
– – 0.02% 130
2013
Q2 		$13K Buy
+319
New +$12.4K 0.03% 76

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Cornerstone Advisors (Washington)'s TEVA Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Teva Pharmaceuticals (TEVA) stake by 8.4% in Q3 2020, selling an estimated $2.35K and leaving 2,435 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Cornerstone Advisors (Washington) first reported a position in TEVA in Q2 2013 and has held it in 28 quarters since. The position peaked at $33K in Q2 2020. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Cornerstone Advisors (Washington) held 2,435 shares of Teva Pharmaceuticals worth $22K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 222 Teva Pharmaceuticals shares in Q3 2020, an estimated $2.35K.
  • Teva Pharmaceuticals made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #363 holding.
  • Cornerstone Advisors (Washington) first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 28 quarters since.
  • Cornerstone Advisors (Washington)'s Teva Pharmaceuticals position peaked at $33K in Q2 2020.
  • 444 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.